Wellgistics Health, Inc. (WGRX)
3.62
-0.01
(-0.28%)
USD |
NASDAQ |
Jun 10, 16:00
3.73
+0.11
(+3.04%)
After-Hours: 18:47
Wellgistics Health Enterprise Value : 37.53M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 37.53M |
| June 08, 2026 | 38.46M |
| June 05, 2026 | 39.25M |
| June 04, 2026 | 39.11M |
| June 03, 2026 | 39.34M |
| June 02, 2026 | 39.01M |
| June 01, 2026 | 38.06M |
| May 29, 2026 | 37.03M |
| May 28, 2026 | 37.74M |
| May 27, 2026 | 36.80M |
| May 26, 2026 | 38.46M |
| May 22, 2026 | 39.25M |
| May 21, 2026 | 42.31M |
| May 20, 2026 | 45.07M |
| May 19, 2026 | 49.97M |
| May 18, 2026 | 50.90M |
| May 15, 2026 | 39.44M |
| May 14, 2026 | 40.77M |
| May 13, 2026 | 41.15M |
| May 12, 2026 | 38.84M |
| May 11, 2026 | 40.53M |
| May 08, 2026 | 39.53M |
| May 07, 2026 | 40.05M |
| May 06, 2026 | 40.64M |
| May 05, 2026 | 41.94M |
| Date | Value |
|---|---|
| May 04, 2026 | 42.03M |
| May 01, 2026 | 42.59M |
| April 30, 2026 | 42.79M |
| April 29, 2026 | 42.51M |
| April 28, 2026 | 43.43M |
| April 27, 2026 | 44.64M |
| April 24, 2026 | 45.30M |
| April 23, 2026 | 46.05M |
| April 22, 2026 | 46.72M |
| April 21, 2026 | 45.88M |
| April 20, 2026 | 45.58M |
| April 17, 2026 | 47.10M |
| April 16, 2026 | 47.52M |
| April 15, 2026 | 47.56M |
| April 14, 2026 | 47.11M |
| April 13, 2026 | 44.06M |
| April 10, 2026 | 44.06M |
| April 09, 2026 | 42.35M |
| April 08, 2026 | 44.89M |
| April 07, 2026 | 45.00M |
| April 06, 2026 | 41.96M |
| April 02, 2026 | 41.08M |
| April 01, 2026 | 41.74M |
| March 31, 2026 | 40.37M |
| March 30, 2026 | 35.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Acro Biomedical Co. Ltd. | 1.932M |
| Stella Diagnostics, Inc. | 20.55M |
| Interpace Biosciences, Inc. | 46.63M |
| Medical Marijuana, Inc. | 2.962M |
| Codexis, Inc. | 231.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.743M |
| Revenue (Quarterly) | 1.560M |
| Total Expenses (Quarterly) | 9.302M |
| EPS Diluted (Quarterly) | -3.242 |
| Gross Profit Margin (Quarterly) | -11.96% |
| Profit Margin (Quarterly) | -496.4% |
| Earnings Yield | -1.15K% |
| Normalized Earnings Yield | -997.12 |